K-numberK252757
Device nameCeQur Simplicity™ On-Demand Insulin Delivery System
ApplicantCequr SA
Product codeOPP
Device classClass II
Decision dateApr 10, 2026
DecisionSubstantially Equivalent
Regulation880.5725
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The CeQur Simplicity™ On-Demand Insulin Delivery System is a sterile, single-use, external insulin delivery device consisting of a disposable insulin patch, fill syringe, and change-by-stickers. It is intended for subcutaneous bolus delivery of insulin to manage diabetes mellitus in adult patients requiring insulin, with the device adhering to skin for up to 7 days.

Technological characteristics

The technological characteristics of the subject device are identical to the predicate device. Both are manual, user-filled, positive displacement insulin delivery systems with a maximum capacity of 2mL, designed for subcutaneous delivery and worn on the body for up to 7 days.

Test standards cited

Not stated in this summary.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →